acetaminophen has been researched along with Hepatitis in 44 studies
Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
paracetamol : A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.
Hepatitis: INFLAMMATION of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| " There are many underlying etiologies, including acetaminophen toxicity, drug induced liver injury, and hepatitis." | 5.01 | Acute liver failure: A review for emergency physicians. ( Koyfman, A; Long, B; Montrief, T, 2019) |
| " In Europe and North America a large proportion of cases are due to acetaminophen and to idiosyncratic drug reactions, whereas reports from emerging countries in Asia and Africa feature viral illnesses, particularly hepatitis B and E." | 4.84 | Etiologies of acute liver failure. ( Lee, WM, 2008) |
| "The aim of the research was to investigate the hepatoprotective properties of the Maitake mushrooms thick extract in the experiment on rats with paracetamol (acetaminophen)-induced hepatitis." | 4.02 | Application of the thick extract from Maitake mushrooms for correction of metabolic disorders under the paracetamol hepatitis in rats. ( Fira, L; Herasymets, I; Medvid, I, 2021) |
| " To study this, we reviewed serum enzyme patterns early in the course of acute liver injury in patients with acute viral hepatitis A and B (n = 51), ischemic hepatitis (n = 20), and acetaminophen injury (n = 26)." | 3.69 | Serum lactic dehydrogenase in the differential diagnosis of acute hepatocellular injury. ( Cassidy, WM; Reynolds, TB, 1994) |
| "Ultrastructural changes were observed in 23 consecutive patients who died from fulminant hepatic failure due to hepatitis B virus (4 cases), sporadic non-A, non-B (7), or paracetamol (acetaminophen) overdose (12) and in 3 patients with subacute hepatic necrosis of unknown cause." | 3.67 | Fulminant hepatitis. An ultrastructural study. ( Fagan, EA; McCaul, TF; Portmann, B; Tovey, G; Williams, R; Zuckerman, AJ, 1986) |
| "A significant proportion of cases of acute liver failure (ALF) do not have an identifiable cause; so called "non A-E," "non A, non B, non C," "seronegative" or "indeterminate" hepatitis." | 2.58 | Systematic review: non A-E, seronegative or indeterminate hepatitis; what is this deadly disease? ( Brennan, PN; Donnelly, MC; Simpson, KJ, 2018) |
| "Hypoxic hepatitis is a clinical condition precipitated by prolonged periods of oxygen deprivation to the liver." | 1.46 | Plasma biomarkers to study mechanisms of liver injury in patients with hypoxic hepatitis. ( Antoine, DJ; Curry, SC; Jaeschke, H; Jenkins, RE; McGill, MR; Olson, JC; Sharpe, MR; Weemhoff, JL; Woolbright, BL, 2017) |
| " Alanine aminotransferase at baseline and following paracetamol administration was noted, as well as dosage and duration of paracetamol, along with participants' demographic details." | 1.46 | Frequency of worsening liver function in severe dengue hepatitis patients receiving paracetamol: A retrospective analysis of hospital data. ( Aslam, F; Hakeem, H; Nasir, N; Siddiqui, F; Syed, AA, 2017) |
| "Curcumin was administered for 7 successive days, while paracetamol was administered at day six of treatment." | 1.40 | Immunohistochemical and molecular study on the protective effect of curcumin against hepatic toxicity induced by paracetamol in Wistar rats. ( Abdo Nassan, M; Ismail, TA; Soliman, MM, 2014) |
| "Liver regeneration may be impaired in acute liver failure due to either inhibition of the proliferative response or ongoing liver cell death." | 1.32 | Activin A and follistatin in acute liver failure. ( Evans, LW; Hughes, RD, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (25.00) | 18.7374 |
| 1990's | 5 (11.36) | 18.2507 |
| 2000's | 5 (11.36) | 29.6817 |
| 2010's | 17 (38.64) | 24.3611 |
| 2020's | 6 (13.64) | 2.80 |
| Authors | Studies |
|---|---|
| Dissanayake, DMDIB | 1 |
| Gunaratne, WMSN | 1 |
| Kumarihamy, KWMPP | 1 |
| Kularatne, SAM | 1 |
| Kumarasiri, PVR | 1 |
| Herasymets, I | 1 |
| Fira, L | 1 |
| Medvid, I | 1 |
| Nawaz, MA | 3 |
| Aleem, A | 3 |
| Hussain, SA | 3 |
| Manzoor, M | 3 |
| Latif, S | 3 |
| Sarwar, MI | 3 |
| Khan, M | 3 |
| Talib, S | 3 |
| Zhang, Y | 2 |
| Biao, Y | 1 |
| Chu, X | 1 |
| Hao, L | 1 |
| Shi, C | 1 |
| Liu, Y | 1 |
| Wang, X | 1 |
| Wang, YQ | 1 |
| Geng, XP | 1 |
| Wang, MW | 1 |
| Wang, HQ | 1 |
| Zhang, C | 1 |
| He, X | 1 |
| Liang, SM | 1 |
| Xu, DX | 1 |
| Chen, X | 1 |
| Yakoob, MY | 1 |
| Ali, SA | 1 |
| Brennan, PN | 1 |
| Donnelly, MC | 1 |
| Simpson, KJ | 1 |
| Montrief, T | 1 |
| Koyfman, A | 1 |
| Long, B | 1 |
| Yang, R | 1 |
| Tonnesseen, TI | 1 |
| Baali, N | 1 |
| Mezrag, A | 1 |
| Bouheroum, M | 1 |
| Benayache, F | 1 |
| Benayache, S | 1 |
| Souad, A | 1 |
| Werawatganon, D | 1 |
| Linlawan, S | 1 |
| Thanapirom, K | 1 |
| Somanawat, K | 1 |
| Klaikeaw, N | 1 |
| Rerknimitr, R | 1 |
| Siriviriyakul, P | 1 |
| Ward, J | 2 |
| Kanchagar, C | 1 |
| Veksler-Lublinsky, I | 1 |
| Lee, RC | 1 |
| McGill, MR | 2 |
| Jaeschke, H | 3 |
| Curry, SC | 2 |
| Ambros, VR | 1 |
| Soliman, MM | 1 |
| Abdo Nassan, M | 1 |
| Ismail, TA | 1 |
| Woolbright, BL | 2 |
| Richards, JA | 1 |
| Bucsaiova, M | 1 |
| Hesketh, EE | 1 |
| Ventre, C | 1 |
| Henderson, NC | 1 |
| Simpson, K | 1 |
| Bellamy, CO | 1 |
| Howie, SE | 1 |
| Anderton, SM | 1 |
| Hughes, J | 1 |
| Wigmore, SJ | 1 |
| Weemhoff, JL | 1 |
| Jenkins, RE | 1 |
| Sharpe, MR | 1 |
| Olson, JC | 1 |
| Antoine, DJ | 1 |
| Syed, AA | 1 |
| Aslam, F | 1 |
| Hakeem, H | 1 |
| Siddiqui, F | 1 |
| Nasir, N | 1 |
| Adukauskiene, D | 1 |
| Dockiene, I | 1 |
| Naginiene, R | 1 |
| Kevelaitis, E | 1 |
| Pundzius, J | 1 |
| Kupcinskas, L | 1 |
| Savino, F | 1 |
| Lupica, MM | 1 |
| Tarasco, V | 1 |
| Locatelli, E | 1 |
| Garazzino, S | 1 |
| Tovo, PA | 1 |
| Moniaux, N | 1 |
| Darnaud, M | 1 |
| Dos Santos, A | 1 |
| Jamot, L | 1 |
| Samuel, D | 1 |
| Amouyal, P | 1 |
| Amouyal, G | 1 |
| Bréchot, C | 1 |
| Faivre, J | 1 |
| Bala, S | 1 |
| Petrasek, J | 1 |
| Mundkur, S | 1 |
| Catalano, D | 1 |
| Levin, I | 1 |
| Alao, H | 1 |
| Kodys, K | 1 |
| Szabo, G | 1 |
| Kubes, P | 1 |
| Mehal, WZ | 1 |
| Hou, HS | 1 |
| Liao, CL | 1 |
| Sytwu, HK | 1 |
| Liao, NS | 1 |
| Huang, TY | 1 |
| Hsieh, TY | 1 |
| Chu, HC | 1 |
| Hughes, RD | 1 |
| Evans, LW | 1 |
| CAREDDU, P | 1 |
| MEREU, T | 1 |
| APOLLONIO, T | 1 |
| EDER, H | 1 |
| Bernal, W | 1 |
| Ma, Y | 1 |
| Smith, HM | 1 |
| Portmann, B | 3 |
| Wendon, J | 1 |
| Vergani, D | 1 |
| Lee, WM | 1 |
| Schmid, M | 1 |
| Cassidy, WM | 1 |
| Reynolds, TB | 1 |
| Evans, PJ | 1 |
| Evans, RW | 1 |
| Bomford, A | 1 |
| Williams, R | 3 |
| Halliwell, B | 1 |
| Bernard, PH | 1 |
| Le Bail, B | 1 |
| Carles, J | 1 |
| Fawaz, R | 1 |
| Balabaud, C | 1 |
| Rosenbaum, J | 1 |
| Bioulac-Sage, P | 1 |
| Hift, RJ | 1 |
| Spearman, CW | 1 |
| Lemmer, ER | 1 |
| Kirsch, RE | 1 |
| Schiff, ER | 1 |
| Ash, SR | 1 |
| Caldwell, CA | 1 |
| Singer, GG | 1 |
| Lowell, JA | 1 |
| Howard, TK | 1 |
| Rustgi, VK | 1 |
| Gazzard, BG | 1 |
| Murray-Lyon, IM | 1 |
| Talbot, IC | 1 |
| Ackerman, Z | 1 |
| Flugelman, MY | 1 |
| Wax, Y | 1 |
| Shouval, D | 1 |
| Levy, M | 1 |
| McCaul, TF | 1 |
| Fagan, EA | 1 |
| Tovey, G | 1 |
| Zuckerman, AJ | 1 |
| Rueff, B | 1 |
| Benhamou, JP | 1 |
| Hammar, CH | 1 |
| Prellwitz, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase 2a Study to Evaluate the Safety and Tolerability of OCR-002 (Ornithine Phenylacetate) in the Treatment of Patients With Acute Liver Failure/Severe Acute Liver Injury[NCT01548690] | Phase 2 | 47 participants (Actual) | Interventional | 2012-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
To evaluate the effect of OCR-002 on ammonia levels in patients with acute liver failure/severe acute liver injury (NCT01548690)
Timeframe: Baseline and 72 Hours
| Intervention | Percent Change (Mean) |
|---|---|
| Maximum Dose Level 3.33 g/24h | 41.2 |
| Maximum Dose Level 6.65 g/24h | 16.6 |
| Maximum Dose Level 10 g/24h | 41.8 |
| Maximum Dose Level 20g/24h | 38.4 |
To evaluate the steady state pharmacokinetic and pharmacodynamic profile of OCR-002 in patients with impaired and intact renal function using urinary phenylacetylglutamine (PAGN) as a surrogate marker (NCT01548690)
Timeframe: 24 Hours after last infusion
| Intervention | micrograms per millileter (Mean) |
|---|---|
| Maximum Dose Level 3.33 g/24h | 65.6 |
| Maximum Dose Level 6.65 g/24h | 32.2 |
| Maximum Dose Level 10 g/24h | 33.4 |
| Maximum Dose Level 20g/24h | 104.9 |
The orientation log focuses on orientation to place, time, and circumstance. There are 10 items on the orientation log, which are scored 0-3. A spontaneous correct response is awarded 3 points. A spontaneous response that is lacking or incorrect, but a correct response is provided following a logical cue is awarded 2 points. A score of 1 is given if spontaneous and cued responses are lacking or incorrect, but a correct response is provided in a recognition format. A score of 0 is given if the spontaneous, cued, or recognition format does not generate a correct answer. Scores from the 10 items are summed and the final score ranges from 0 to 30. (NCT01548690)
Timeframe: 30 Days
| Intervention | units on a scale (Mean) |
|---|---|
| Maximum Dose Level 3.33 g/24h | 23.8 |
| Maximum Dose Level 6.65 g/24h | 24.0 |
| Maximum Dose Level 10 g/24h | 24.0 |
| Maximum Dose Level 20g/24h | 24.0 |
The West Haven Criteria (WHC) for Hepatic Encephalopathy measures the severity of encephalopathy and patient's level of consciousness. The scale ranges from 0 to 4; a minimum score of 0 represents a better outcome, and a maximum total score of 4 represents a worse outcome. A score of 0 corresponds to normal consciousness and behavior and normal neurological examination. A score of 1 corresponds to mild lack of awareness, shortened attention span, and impaired addition or subtraction; mild asterixis or tremor. A score of 2 corresponds to lethargy, disorientated or inappropriate behavior, obvious asterixis; slurred speech. A score of 3 corresponds to somnolent but arousable, gross disorientation or bizarre behavior, muscle rigidity and clonus; hyperreflexia. A score of 4 corresponds to coma and decerebrate posturing. (NCT01548690)
Timeframe: 120 hours from start of infusion
| Intervention | units on a scale (Mean) |
|---|---|
| Maximum Dose Level 3.33 g/24h | 2.4 |
| Maximum Dose Level 6.65 g/24h | 3.2 |
| Maximum Dose Level 10 g/24h | 1.6 |
| Maximum Dose Level 20g/24h | 1.8 |
To evaluate the safety and tolerability of OCR-002 in patients with acute liver failure/severe acute liver injury (NCT01548690)
Timeframe: 30 Days
| Intervention | Participants (Count of Participants) |
|---|---|
| Maximum Dose Level 3.33 g/24h | 0 |
| Maximum Dose Level 6.65 g/24h | 0 |
| Maximum Dose Level 10 g/24h | 0 |
| Maximum Dose Level 20g/24h | 0 |
10 reviews available for acetaminophen and Hepatitis
| Article | Year |
|---|---|
Systematic review: non A-E, seronegative or indeterminate hepatitis; what is this deadly disease?
Topics: Acetaminophen; Autoimmune Diseases; Chemical and Drug Induced Liver Injury; Hepatitis; Humans; Liver | 2018 |
Acute liver failure: A review for emergency physicians.
Topics: Acetaminophen; Chemical and Drug Induced Liver Injury; Emergency Service, Hospital; Hepatic Encephal | 2019 |
DAMPs and sterile inflammation in drug hepatotoxicity.
Topics: Acetaminophen; Alarmins; Analgesics, Non-Narcotic; Biomarkers; Chemical and Drug Induced Liver Injur | 2019 |
Sterile inflammation in acute liver injury: myth or mystery?
Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Cholestasis; Hepatitis; HMGB1 Protei | 2015 |
Sterile inflammation in the liver.
Topics: Acetaminophen; Adenosine Triphosphate; Caspase 1; Chemical and Drug Induced Liver Injury; Chemotaxis | 2012 |
Etiologies of acute liver failure.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Budd-Chiari Syndrome; Drug-Related Side Effects and Adverse | 2008 |
Update in hepatology.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Hepatitis; Hepatitis, Viral, Human; Humans; Liver Cirrhosis | 1999 |
Treatment of acetaminophen-induced hepatitis and fulminant hepatic failure with extracorporeal sorbent-based devices.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Charcoal; Hemoperfusion; Hepatitis; Humans; Liver Failure; | 2002 |
Acute liver injury.
Topics: Acetaminophen; Acute Disease; Chemical and Drug Induced Liver Injury; Cholestasis; Halothane; Hepati | 1975 |
Acute hepatic necrosis and fulminant hepatic failure.
Topics: Acetaminophen; Acute Disease; Alanine Transaminase; Animals; Blood Coagulation Disorders; Brain Dise | 1973 |
1 trial available for acetaminophen and Hepatitis
| Article | Year |
|---|---|
[The glucuronide pattern after peroral dosage with acetanilide in chronic hepatitis and liver cirrhosis].
Topics: Acetaminophen; Acetanilides; Glucosyltransferases; Glucuronates; Hepatitis; Humans; Liver; Liver Cir | 1966 |
33 other studies available for acetaminophen and Hepatitis
| Article | Year |
|---|---|
Use of intravenous N-acetylcysteine in acute severe hepatitis due to severe dengue infection: a case series.
Topics: Acetaminophen; Acetylcysteine; Adult; Animals; Hepatitis; Humans; Infant, Newborn; Male; Retrospecti | 2021 |
Application of the thick extract from Maitake mushrooms for correction of metabolic disorders under the paracetamol hepatitis in rats.
Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Grifola; Hepatitis; Liver; Male; Met | 2021 |
Hepatoprotective effect of methanolic extract of Iris florentina L. on paracetamol-induced liver toxicity in rats.
Topics: Acetaminophen; Animals; Hepatitis; Methanol; Plant Extracts; Rats | 2022 |
Hepatoprotective effect of methanolic extract of Iris florentina L. on paracetamol-induced liver toxicity in rats.
Topics: Acetaminophen; Animals; Hepatitis; Methanol; Plant Extracts; Rats | 2022 |
Hepatoprotective effect of methanolic extract of Iris florentina L. on paracetamol-induced liver toxicity in rats.
Topics: Acetaminophen; Animals; Hepatitis; Methanol; Plant Extracts; Rats | 2022 |
Hepatoprotective effect of methanolic extract of Iris florentina L. on paracetamol-induced liver toxicity in rats.
Topics: Acetaminophen; Animals; Hepatitis; Methanol; Plant Extracts; Rats | 2022 |
Protective effect of Chushizi (Fructus Broussonetiae) on acetaminophen-induced rat hepatitis by inhibiting the Toll-like receptor 3/c-Jun N-terminal kinase/c-jun/c-fos/janus protein tyrosine kinase/activators of transcription 3 pathway.
Topics: Acetaminophen; Animals; Hepatitis; Humans; Liver; Male; Phosphorylation; Proto-Oncogene Proteins c-f | 2020 |
Vitamin D deficiency exacerbates hepatic oxidative stress and inflammation during acetaminophen-induced acute liver injury in mice.
Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Cytokines; Disease Models, Animal; H | 2021 |
Comment on Ahsan Ali Syed et al (J Pak Med Assoc 2017; 67: 400-404) Frequency of worsening liver function in severe dengue hepatitis patients receiving paracetamol: A retrospective analysis of hospital data.
Topics: Acetaminophen; Hepatitis; Humans; Retrospective Studies; Severe Dengue | 2017 |
Response to comment on Ahsan Ali Syed et al (J Pak Med Assoc 2017; 67: 400-404 Frequency of worsening liver function in severe dengue hepatitis patients receiving paracetamol: A retrospective analysis of hospital data.
Topics: Acetaminophen; Hepatitis; Humans; Retrospective Studies; Severe Dengue | 2017 |
Anti-inflammatory and Antioxidant Effects of
Topics: Acetaminophen; Animals; Anti-Inflammatory Agents; Antioxidants; Biphenyl Compounds; Cells, Cultured; | 2020 |
Aloe vera attenuated liver injury in mice with acetaminophen-induced hepatitis.
Topics: Acetaminophen; Aloe; Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Glutathione; Hep | 2014 |
Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis.
Topics: Acetaminophen; Acetylcysteine; Alanine Transaminase; Hepatitis; Humans; Ischemia; MicroRNAs; Poisoni | 2014 |
Immunohistochemical and molecular study on the protective effect of curcumin against hepatic toxicity induced by paracetamol in Wistar rats.
Topics: Acetaminophen; Acute-Phase Proteins; Analgesics, Non-Narcotic; Animals; Antioxidants; Chemical and D | 2014 |
Acute Liver Injury Is Independent of B Cells or Immunoglobulin M.
Topics: Acetaminophen; Acute Lung Injury; Animals; B-Lymphocytes; Chemical and Drug Induced Liver Injury; Di | 2015 |
Plasma biomarkers to study mechanisms of liver injury in patients with hypoxic hepatitis.
Topics: Acetaminophen; Adolescent; Adult; Alanine Transaminase; Apoptosis; Biomarkers; DNA Fragmentation; DN | 2017 |
Frequency of worsening liver function in severe dengue hepatitis patients receiving paracetamol: A retrospective analysis of hospital data.
Topics: Acetaminophen; Adolescent; Adult; Analgesics, Non-Narcotic; Female; Hepatitis; Humans; Liver; Liver | 2017 |
Acute liver failure in Lithuania.
Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Bilirubin; Chemical and Drug Induced Liver Injury; Co | 2008 |
Fulminant hepatitis after 10 days of acetaminophen treatment at recommended dosage in an infant.
Topics: Acetaminophen; Drug Administration Schedule; Hepatitis; Humans; Infant; Liver Failure, Acute; Male; | 2011 |
[HIP/PAP, a new drug for acute liver failure].
Topics: Acetaminophen; Acute Disease; Animals; Antigens, Neoplasm; Biomarkers, Tumor; Chemical and Drug Indu | 2012 |
Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases.
Topics: Acetaminophen; Alanine Transaminase; Animals; Biomarkers; Chemical and Drug Induced Liver Injury; Cp | 2012 |
Deficiency of interleukin-15 enhances susceptibility to acetaminophen-induced liver injury in mice.
Topics: Acetaminophen; Animals; Antibodies, Neutralizing; Chemical and Drug Induced Liver Injury; Disease Su | 2012 |
Activin A and follistatin in acute liver failure.
Topics: Acetaminophen; Activins; Adolescent; Adult; Analgesics, Non-Narcotic; Biomarkers; Enzyme-Linked Immu | 2003 |
[Studies on glycuro-conjugation in infectious hepatitis. II. The half-life of N-acetyl-p-aminophenol as test of hepatic function].
Topics: Acetaminophen; Child; Half-Life; Hepatitis; Hepatitis A; Humans; Infant; Liver Function Tests | 1961 |
CHRONIC TOXICITY STUDIES ON PHENACETIN, N-ACETYL-P-AMINOPHENOL (NAPA) AND ACETYLSALICYLIC ACID ON CATS.
Topics: Acetaminophen; Analgesics; Analgesics, Non-Narcotic; Antipyretics; Aspirin; Cats; Chemical and Drug | 1964 |
The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Antibodies, Viral; Autoantibodies; Autoantigens; Coh | 2007 |
[Does therapy for common liver diseases exist?].
Topics: Acetaminophen; Hepatitis; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Prednisone | 1983 |
Serum lactic dehydrogenase in the differential diagnosis of acute hepatocellular injury.
Topics: Acetaminophen; Acute Disease; Alanine Transaminase; Aspartate Aminotransferases; Chemical and Drug I | 1994 |
Metal ions catalytic for free radical reactions in the plasma of patients with fulminant hepatic failure.
Topics: Acetaminophen; Adult; Aged; Antioxidants; Chelating Agents; Copper; Female; Free Radicals; Hepatic E | 1994 |
Morphology of hepatic stellate cells in patients with fulminant or subfulminant hepatitis requiring liver transplantation.
Topics: Acetaminophen; Actins; Adult; Aged; Amanita; Autoimmune Diseases; Biomarkers; Cell Differentiation; | 1996 |
A jaundiced look at the management of hepatitis?
Topics: Acetaminophen; Alcohol Drinking; Chemical and Drug Induced Liver Injury; Female; Halothane; Hepatiti | 1997 |
Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage.
Topics: Acetaminophen; Adolescent; Adult; Age Factors; Aged; Amanita; Autopsy; Brain Edema; Drug Hypersensit | 1975 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 23--1977.
Topics: Acetaminophen; Acute Disease; Adolescent; Arthritis, Juvenile; Aspirin; Brain Death; Brain Edema; Ch | 1977 |
Hepatitis during measles in young adults: possible role of antipyretic drugs.
Topics: Acetaminophen; Adolescent; Adult; Aminopyrine; Chemical and Drug Induced Liver Injury; Dipyrone; Fem | 1989 |
Fulminant hepatitis. An ultrastructural study.
Topics: Acetaminophen; Adolescent; Adult; Autopsy; Chemical and Drug Induced Liver Injury; Female; Hepatitis | 1986 |
Editorial: Towards an artificial liver.
Topics: Acetaminophen; Aspartic Acid; Brain Chemistry; Charcoal; Glutamates; Hepatic Encephalopathy; Hepatit | 1974 |